A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis
- PMID: 20186457
- DOI: 10.1007/s10157-010-0271-6
A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis
Abstract
A 67-year-old woman was admitted to our hospital because of anasarca due to refractory nephrotic syndrome and chronic renal insufficiency. Laboratory data indicated serum total protein of 4.8 g/dl, albumin of 1.5 g/dl, creatinine of 1.9 mg/dl and BUN of 17 mg/dl. Urinary protein excretion was 7.8 g/day. Because of severe atrophy of both kidneys, neither renal biopsy nor immunosuppressive treatment was performed. Since conservative management including bed rest, diet therapy, limitation of water intake and administration of diuretics was not effective, peritoneal dialysis therapy using icodextrin only at night was started. The amount of water removal was steadily secured without progressing renal dysfunction or decreasing urine volume. From day 290 onward, the urinary protein excretion was decreased to show complete remission and urine volume increased. On day 528, peritoneal dialysis was discontinued, and thereafter only peritoneal lavage was performed. On day 858, the catheter was removed from the abdominal cavity, and thereafter diuretics could be discontinued. The reason for the dramatic reduction of urinary protein in this patient is unclear. However, it is possible that the primary disease such as membranous nephritis showed remission while the patient was undergoing icodextrin peritoneal dialysis, which preserves renal function but not extracorporeal ultrafiltration or hemodialysis. Icodextrin peritoneal dialysis may be an alternative to hemodialysis for refractory fluid overload in patients with nephrotic syndrome and may have the advantage of preserving renal function.
Similar articles
-
Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.CEN Case Rep. 2012 May;1(1):16-23. doi: 10.1007/s13730-012-0006-5. Epub 2012 Apr 25. CEN Case Rep. 2012. PMID: 28509154 Free PMC article.
-
Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.Nephrol Dial Transplant. 2003 Jul;18(7):1383-7. doi: 10.1093/ndt/gfg120. Nephrol Dial Transplant. 2003. PMID: 12808177 Clinical Trial.
-
Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study.Perit Dial Int. 2007 May-Jun;27(3):260-6. Perit Dial Int. 2007. PMID: 17468473 Clinical Trial.
-
Icodextrin and peritoneal dialysis: advantages and new applications.Int Urol Nephrol. 2018 Mar;50(3):495-500. doi: 10.1007/s11255-017-1647-2. Epub 2017 Jul 3. Int Urol Nephrol. 2018. PMID: 28674854 Review.
-
Recommendations for the use of icodextrin in peritoneal dialysis patients.Nephrology (Carlton). 2003 Feb;8(1):1-7. doi: 10.1046/j.1440-1797.2003.00117.x. Nephrology (Carlton). 2003. PMID: 15012742 Review.
Cited by
-
Peritoneal dialysis outcomes in patients with nephrotic syndrome: a propensity score-matched cohort study.Ren Fail. 2020 Nov;42(1):684-692. doi: 10.1080/0886022X.2020.1792316. Ren Fail. 2020. PMID: 32686569 Free PMC article.
-
Successful treatment of peritoneal dialysis for two patients with refractory nephrotic syndrome and acute kidney injury: a case report.Front Med (Lausanne). 2023 Oct 18;10:1263780. doi: 10.3389/fmed.2023.1263780. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37920598 Free PMC article.
-
Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.CEN Case Rep. 2012 May;1(1):16-23. doi: 10.1007/s13730-012-0006-5. Epub 2012 Apr 25. CEN Case Rep. 2012. PMID: 28509154 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical